Ataxia-Telangiectasia Center

Mission

• Provide cutting edge medical care to individuals affected by AT
• Perform state-of-the art research addressing the most critical and pertinent questions regarding the mechanisms of neurological dysfunction in Ataxia-Telangiectasia (AT)
• Translate basic science research findings into clinical therapies
• Educate medical professionals and the community about AT

Focus

• Primary and sub-specialty physicians working collaboratively to provide complete medical care for AT patients thus improving overall health and quality of life for AT patients
• The AT research center will spearhead a focused effort in performing basic and translational research aimed at treating the neurological outcomes of AT, which currently remain untreatable
• Enhance the already excellent reputation of both the medical school and the hospital by attracting patients from both a local and national patient pool
• Obtain basic science and clinical research funding. Research grants will enhance the research reputation of both institutions and also provide overhead.
• Provide outstanding and unique opportunities for teaching graduate students, medical students, residents, and fellows.

Locations

• Clinical Outpatient Service
  • UTHealth Houston Professional Building
• Clinical Inpatient Service
  • Memorial Hermann Health Care System (children and adult patients)

Dedicated Center Providers

Mary Kay Koenig, MD

Clinical Director
Professor, Child & Adolescent Neurology
Director, Center for the Treatment of Pediatric Neurodegenerative Diseases

Visit Dr. Koenig's Faculty Profile

S. Nick Russo, MD

Clinical Associate Director
Assistant Professor, Child & Adolescent Neurology

Visit Dr. Russo's Faculty Profile